{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:35:39Z","timestamp":1771403739881,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.08.093","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T07:31:58Z","timestamp":1506065518000},"page":"1549-1555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study"],"prefix":"10.1016","volume":"95","author":[{"given":"Jie-En","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Long","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.08.093_bib0005","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00296-013-2772-6","article-title":"Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis","volume":"33","author":"Machado","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2017.08.093_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","article-title":"Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level","volume":"32","author":"Ertenli","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2017.08.093_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3899\/jrheum.100469","article-title":"Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5","volume":"38","author":"Assassi","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0020","doi-asserted-by":"crossref","first-page":"139608","DOI":"10.1155\/2013\/139608","article-title":"Health care costs associated with ankylosing spondylitis in Turkey: an analysis from nationwide real-world data","volume":"2013","author":"Baser","year":"2013","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn\u2019s disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2017.08.093_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Assessment of SpondyloArthritis international S. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2017.08.093_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/BOR.0b013e32835257c5","article-title":"Baseline predictors of response to TNF-alpha blocking therapy in ankylosing spondylitis","volume":"24","author":"Arends","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/keq078","article-title":"Evaluation of the treatment effect of NSAIDs\/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis","volume":"49","author":"Escalas","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.biopha.2017.08.093_bib0045","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00296-010-1651-7","article-title":"The serum levels of resistin in ankylosing spondylitis patients: a pilot study","volume":"32","author":"Kocabas","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2017.08.093_bib0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0060","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.7314\/APJCP.2012.13.5.1971","article-title":"Significance and expression of aquaporin 1, 3, 8 in cervical carcinoma in Xinjiang Uygur women of China","volume":"13","author":"Shi","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2017.08.093_bib0065","first-page":"14206","article-title":"Use of aquaporins 1 and 5 levels as a diagnostic marker in mild-to-moderate adult-onset asthma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1471-4159.2010.06630.x","article-title":"Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?","volume":"113","author":"Laird","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2017.08.093_bib0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/keq028","article-title":"TNF-alpha-induced aquaporin 9 in synoviocytes from patients with OA and RA","volume":"49","author":"Nagahara","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.biopha.2017.08.093_bib0080","doi-asserted-by":"crossref","first-page":"862969","DOI":"10.1155\/2014\/862969","article-title":"Drug retention rates and treatment discontinuation among anti-TNF-alpha agents in psoriatic arthritis and ankylosing spondylitis in clinical practice","volume":"2014","author":"Fabbroni","year":"2014","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.biopha.2017.08.093_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054788","article-title":"5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines","volume":"8","author":"Sakai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.093_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fsi.2013.10.011","article-title":"Characterization of three pro-inflammatory cytokines, TNFalpha1, TNFalpha2 and IL-1beta, in cage-reared Atlantic bluefin tuna Thunnus thynnus","volume":"36","author":"Lepen Pleic","year":"2014","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0100","doi-asserted-by":"crossref","first-page":"13937","DOI":"10.1074\/jbc.M113.534594","article-title":"Critical role of aquaporins in interleukin 1beta (IL-1beta)-induced inflammation","volume":"289","author":"Rabolli","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.08.093_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tice.2012.10.004","article-title":"Aquaporin 1 (AQP1) expression in experimentally induced osteoarthritic knee menisci: an in vivo and in vitro study","volume":"45","author":"Musumeci","year":"2013","journal-title":"Tissue Cell"},{"key":"10.1016\/j.biopha.2017.08.093_bib0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.aanat.2010.01.001","article-title":"Expression of aquaporin 1 (AQP1) in human synovitis","volume":"192","author":"Mobasheri","year":"2010","journal-title":"Ann. Anat."},{"key":"10.1016\/j.biopha.2017.08.093_bib0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.acthis.2012.01.001","article-title":"Aquaporin 1 expression in human temporomandibular disc","volume":"114","author":"Loreto","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.biopha.2017.08.093_bib0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1600-0714.2012.01156.x","article-title":"Expression and localization of aquaporin-1 in temporomandibular joint disc with internal derangement","volume":"41","author":"Loreto","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.biopha.2017.08.093_bib0125","first-page":"1241","article-title":"Increased aquaporin 1 expression in the tunica albuginea of Peyronie's disease patients: an in vivo pilot study","volume":"31","author":"Castorina","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0130","first-page":"987","article-title":"N-Cadherin, ADAM-10 and Aquaporin 1 expression in lung tissue exposed to fluoro-edenite fibers: an immunohistochemical study","volume":"30","author":"Musumeci","year":"2015","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2017.08.093_bib0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0300060516628704","article-title":"Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients","volume":"44","author":"Walker","year":"2016","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.biopha.2017.08.093_bib0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/03009742.2016.1152399","article-title":"Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis","volume":"45","author":"Gamez-Nava","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/2317-1782\/20152014167","article-title":"Auditory-perceptual evaluation of the degree of vocal deviation: correlation between the Visual Analogue Scale and Numerical Scale","volume":"27","author":"Martins","year":"2015","journal-title":"Codas"},{"key":"10.1016\/j.biopha.2017.08.093_bib0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7754\/Clin.Lab.2015.150801","article-title":"Elevated serum levels of sclerostin are associated with high disease activity and functional impairment in patients with axial spondyloarthritis","volume":"62","author":"Muntean","year":"2016","journal-title":"Clin. Lab."},{"key":"10.1016\/j.biopha.2017.08.093_bib0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9150(01)00581-0","article-title":"Differential expression of ribosomal L31, Zis, gas-5 and mitochondrial mRNAs following oxidant induction of proliferative vascular smooth muscle cell phenotypes","volume":"160","author":"Lu","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.08.093_bib0165","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.08.093_bib0170","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2017.08.093_bib0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2005.041129","article-title":"Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2017.08.093_bib0180","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/rheumatology\/kes066","article-title":"First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"51","author":"van den Berg","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.biopha.2017.08.093_bib0185","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2017.08.093_bib0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/annrheumdis-2015-208677","article-title":"Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis","volume":"76","author":"Lau","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2017.08.093_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12950-017-0153-8","article-title":"Overexpression of aquaporin 4 in articular chondrocytes exacerbates the severity of adjuvant-induced arthritis in rats: an in vivo and in vitro study","volume":"14","author":"Cai","year":"2017","journal-title":"J. Inflammation (Lond.)"},{"key":"10.1016\/j.biopha.2017.08.093_bib0200","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3109\/14397595.2015.1029221","article-title":"Upregulation of BMP-2 expression in peripheral blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitis","volume":"25","author":"Chen","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","article-title":"BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology","volume":"44","author":"Keat","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.biopha.2017.08.093_bib0210","first-page":"1","article-title":"Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation","volume":"10","author":"Liu","year":"2012","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1995-7645(12)60205-3","article-title":"Expression of IL-2 and IL-11 and its significance in patients with ankylosing spondylitis","volume":"6","author":"Liu","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"Suppl","key":"10.1016\/j.biopha.2017.08.093_bib0220","first-page":"318","article-title":"Aquaporin 1 water channel is overexpressed in the plasma membranes of pancreatic ducts in patients with autoimmune pancreatitis","volume":"56","author":"Ko","year":"2009","journal-title":"J. Med. Invest."},{"key":"10.1016\/j.biopha.2017.08.093_bib0225","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1096\/fj.09-140012","article-title":"Epigenetic control of aquaporin 1 expression by the amyloid precursor protein","volume":"23","author":"Huysseune","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.08.093_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014226","article-title":"Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease","volume":"5","author":"Hansel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.093_bib0235","doi-asserted-by":"crossref","first-page":"C975","DOI":"10.1152\/ajpcell.00180.2003","article-title":"Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease","volume":"286","author":"Jablonski","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0240","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1096\/fj.11-182808","article-title":"Defective macrophage function in aquaporin-3 deficiency","volume":"25","author":"Zhu","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2017.08.093_bib0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009742.2014.956142","article-title":"Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study","volume":"44","author":"Sveaas","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2017.08.093_bib0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10067-006-0283-5","article-title":"Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis","volume":"26","author":"Bal","year":"2007","journal-title":"Clin. Rheumatol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217316840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217316840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:51:43Z","timestamp":1771401103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217316840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"alternative-id":["S0753332217316840"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.093","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}